keyword
https://read.qxmd.com/read/38270325/clinical-features-of-macrophage-activation-syndrome-in-adult-dermatomyositis-%C3%A2-a-single-center-retrospective-case-control-study
#21
JOURNAL ARTICLE
Dingxian Zhu, Shuni Ying, Changyi Yang, Sheng Li, Shunli Tang, Chuanyin Sun, Hong Fang, Jianjun Qiao
BACKGROUND: Little is known about the features of macrophage activation syndrome (MAS) in dermatomyositis, especially the association between rapidly progressive interstitial lung disease (RP-ILD) and MAS. OBJECTIVE: To determine the characteristics of MAS in patients with dermatomyositis and their association with RP-ILD. METHODS: This was a retrospective cohort study of 201 dermatomyositis patients at the First Affiliated Hospital of Zhejiang University over a 10-year period...
January 2024: Immunity, Inflammation and Disease
https://read.qxmd.com/read/38267764/-hemophagocytic-lymphohistiocytosis-and-macrophage-activation-syndrome-a-multidisciplinary-challenge
#22
REVIEW
Nikolas Ruffer, Ricardo Kosch, Katja Weisel, Ina Kötter, Martin Krusche
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that is characterized by hyperferritinemia, cytopenia, disseminated intravascular coagulopathy and functional disorders of the liver and the central nervous system. The term macrophage activation syndrome is predominantly used for secondary HLH in the context of autoimmune diseases (e.g., systemic juvenile idiopathic arthritis). In addition, malignancies and genetic inborn errors of immunity can predispose to the development of HLH...
January 24, 2024: Zeitschrift Für Rheumatologie
https://read.qxmd.com/read/38263470/infectious-diseases-evaluation-of-the-child-with-suspected-hemophagocytic-lymphohistiocytosis
#23
JOURNAL ARTICLE
Maria Deza Leon, William R Otto, Lara Danziger-Isakov, Ashish Kumar, Felicia Scaggs Huang
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of excessive and maladaptive inflammation. Classic clinical and laboratory features associated with the diagnosis of HLH, including fever, cytopenias, hyperferritinemia and splenomegaly, are not specific to HLH and can be caused by infections. Fulfillment of these clinical and laboratory criteria alone are not sufficient to diagnose HLH or initiate HLH-directed therapies. In this manuscript, we review the pathogenesis of HLH and HLH-like syndromes associated with infection...
January 23, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38255312/prevalence-and-characteristics-of-metabolic-hyperferritinemia-in-a-population-based-central-european-cohort
#24
JOURNAL ARTICLE
Sophie Gensluckner, Bernhard Wernly, Florian Koutny, Georg Strebinger, Stephan Zandanell, Lars Stechemesser, Bernhard Paulweber, Bernhard Iglseder, Eugen Trinka, Vanessa Frey, Patrick Langthaler, Georg Semmler, Luca Valenti, Elena Corradini, Christian Datz, Elmar Aigner
BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort. METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria...
January 17, 2024: Biomedicines
https://read.qxmd.com/read/38251692/association-of-covid-with-mycosis-in-general
#25
JOURNAL ARTICLE
Gurpreet Kaur, Rajinder Kaur, Sumanpreet Kaur, Manpreet Kaur
BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 is a respiratory disease which created havoc worldwide, was accompanied by another peculiar, otherwise rare, secondary fungal infection Mucormycosis which was observed at exceptionally high incidence in India during the second wave of COVID-19. The article explores possible links between the two infectious diseases to understand a higher-than-normal occurrence of Mucormycosis in COVID-19 patients. Coronavirus enters the patients through ACE-2 and many other receptors like- NRP-1, TfR, CD-126, and CD-26...
January 19, 2024: Infectious Disorders Drug Targets
https://read.qxmd.com/read/38249222/a-case-report-kikuchi-disease-associated-with-a-positive-auto-immune-panel-triggered-by-covid-19-infection
#26
Andrew Graef, Aimee Willett, Andrew-Huy Dang, Jayalakshmi Balakrishna, Charles Nicely, Robert Baiocchi
Kikuchi disease (KD) is a rare, benign inflammatory condition characterized by fever and cervical lymphadenopathy. While the pathogenesis is largely unknown, Kikuchi disease onset has strong associations with various infections and autoimmune conditions. There are few reported cases of Kikuchi disease triggered by coronavirus disease 2019 (COVID-19) infection or vaccination. A 43-year-old Filipina female with a history of anemia and recent uncomplicated COVID-19 infection one month prior presented with a one-month history of progressive weakness, fatigue, anorexia with 30-pound weight loss, fevers, odynophagia, and new-onset hematemesis...
December 2023: Curēus
https://read.qxmd.com/read/38195430/hyperferritinemia-as-a-factor-associated-with-poor-prognosis-in-covid-19-patients
#27
JOURNAL ARTICLE
Nuhad Mohammed Al-Dulaimi, Mahmood Jassim Mohammed, Saad T Mutlk, Khalid F Al-Rawi, Hameed Hussein Ali, Bilal J M Aldahham, Faisal Al-Ani, Osamah Al-Ani, Yaqout A Hamed, Aus T Ali
Worldwide, hundreds of millions of people have been infected with COVID-19 since December 2019; however, about 20% or less developed severe symptoms. The main aim of the current study was to  assess  the  relationship  between  the  severity of Covid-19 and different clinical and laboratory parameters. A total number of 466 Arabs have willingly joined this prospective cohort. Out of the total number, 297 subjects (63.7%) had negative COVID-19 tests, and thus, they were recruited as controls, while 169 subjects (36...
2024: Ceská a Slovenská Farmacie
https://read.qxmd.com/read/38187172/tumor-lysis-syndrome-followed-by-tumor-regression-after-covid-19-in-a-patient-with-chronic-lymphocytic-leukemia
#28
JOURNAL ARTICLE
Masato Yasumi, Yudai Yamamoto, Kimimori Kamijo, Tsuyoshi Kamae, Masaya Yamato, Takahiro Karasuno
Coronavirus disease 2019 (COVID-19) can become lethal in patients with hematological malignancies; however, several cases of tumor regression after COVID-19 have been described, and the precise mechanism behind this paradoxical effect is unknown. Herein, we describe a case of Tumor lysis syndrome (TLS) followed by tumor regression after COVID-19. A 72-year-old woman with untreated chronic lymphocytic leukemia was admitted to our hospital with SARS-CoV-2 antigen-positive pneumonia. On admission, her anti-SARS-CoV-2 spike antibody was negative despite receiving two prior vaccinations...
January 2024: International cancer conference journal
https://read.qxmd.com/read/38185645/hyperferritinemia-as-a-factor-associated-with-poor-prognosis-in-covid-19-patients
#29
JOURNAL ARTICLE
Nuhad Mohammed Al-Dulaimi, Mahmood Jassim Mohammed, Saad T Mutlk, Khalid F Al-Rawi, Hameed Hussein Ali, Bilal J M Aldahham, Faisal Al-Ani, Osamah Al-Ani, Yaqout A Hamed, Aus T Ali
Worldwide, hundreds of millions of people have been infected with COVID-19 since December 2019; however, about 20% or less developed severe symptoms. The main aim of the current study was to  assess  the  relationship  between  the  severity of Covid-19 and different clinical and laboratory parameters. A total number of 466 Arabs have willingly joined this prospective cohort. Out of the total number, 297 subjects (63.7%) had negative COVID-19 tests, and thus, they were recruited as controls, while 169 subjects (36...
2024: Ceská a Slovenská Farmacie
https://read.qxmd.com/read/38176299/metagenomic-next-generation-sequencing-on-bronchoalveolar-lavage-fluid-to-contribute-to-diagnosis-of-subclinical-pulmonary-tuberculosis-with-scarce-sputum-and-negative-smear-in-a-patient-mimicking-adult-onset-still-s-disease-a-case-report
#30
Yanchun Guan, Xiao Ma, Xiangnan Sun, Hongfeng Zhang
Extremely high serum ferritin, which is regarded as a marker of adult-onset still's disease (AOSD), has been rarely observed in patients with TB. We report a case of TB diagnose by metagenomic next-generation sequencing(mNGS) who presented with clinical criteria of AOSD and extreme hyperferritinemia, which posed a diagnostic confusion. TB presenting with major clinical criteria of AOSD should be notable. Since TB remains a potentially curable disease, an awareness of its' protean manifestations is essential...
March 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38171563/-analysis-of-a-child-with-cln1-neuronal-ceroid-lipofuscinosis-in-conjunct-with-hereditary-hyperferinemia-cataract-syndrome
#31
JOURNAL ARTICLE
Fan Zhou, Jiandong Wang, Yao Wang, Haiying Li, Yu Su, Yongwei Wei, Huaili Wang
OBJECTIVE: To analyze the clinical data and genetic characteristics of a child with CLN1 neuronal ceroid lipofuscinosis in conjunct with Hereditary hyperferritinemia cataract syndrome (HHCS). METHODS: A child who was admitted to the PICU of the First Affiliated Hospital of Zhengzhou University in November 2020 was selected as the study subject. Clinical data of the child was collected. Genetic testing was carried out for the child, and the result was analyzed in the light of literature review to explore the clinical and genetic characteristics to facilitate early identification...
January 10, 2024: Zhonghua Yi Xue Yi Chuan Xue za Zhi, Zhonghua Yixue Yichuanxue Zazhi, Chinese Journal of Medical Genetics
https://read.qxmd.com/read/38158295/-diagnosis-and-evaluation-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld
#32
REVIEW
C M Canivet, S Faure
Non-alcoholic fatty liver disease (NAFLD) or recently called Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), is the leading cause of liver disease, with an estimated worldwide prevalence of 25%. MASLD is suspected, in a metabolic condition, in the presence of hepatic steatosis, moderate hepatic cytolysis or hyperferritinemia. The severity of the disease depends on the stage of liver fibrosis, which can be suspected in clinical practice by simple blood tests such as the FIB-4 or NAFLD fibrosis Score...
January 2024: La Revue de Médecine Interne
https://read.qxmd.com/read/38154979/-analysis-of-9-cases-of-drug-induced-hypersensitivity-syndrome-related-hemophagocytic-lymphohistiocytosis
#33
JOURNAL ARTICLE
Y Z Zhao, H H Ma, D Wang, H Y Lian, T Y Wang, R Zhang
Objective: To analyze the clinical features,treatment and prognosis of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis (DIHS-HLH). Methods: This was a retrospective case study. Clinical characteristics, laboratory results, treatment and prognosis of 9 patients diagnosed with DIHS-HLH in Beijing Children's hospital between January 2020 and December 2022 were summarized. Kaplan-Meier survival analysis was used to calculate the overall survival rate. Results: Among all 9 cases, there were 6 males and 3 females, with the age ranged from 0...
January 2, 2024: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics
https://read.qxmd.com/read/38152323/effect-of-viral-eradication-with-direct-acting-antiviral-agents-on-iron-parameters-in-patients-with-chronic-hepatitis-c-and-hyperferritinemia
#34
JOURNAL ARTICLE
Agustin Castiella, María José Sánchez-Iturri, Iratxe Urreta, Silvia Torrente, Ana Alcorta, Eva Zapata
BACKGROUND: Patients with chronic hepatitis C are at increased risk for hyperferritinemia (HF). Abnormalities of serum iron parameters are frequently observed in patients with chronic hepatitis C (CHC). About a third of patients have increased iron parameters. Recently, studies on the effect of direct-acting antiviral agents (DAAs) in HCV eradication in patients with increased serum iron has been published, demonstrating the restoration of normal iron status. The aim of this study was to evaluate the effect of viral eradication with DDAs in patients with CHC and HF...
December 2023: Canadian liver journal
https://read.qxmd.com/read/38130347/clinical-experience-of-a-long-acting-pegylated-erythropoietin-stimulating-agent-in-pediatric-chronic-kidney-disease
#35
JOURNAL ARTICLE
Maria Anna Bantounou, Angela Lamb, David Young, Ian James Ramage, Ben Christopher Reynolds
OBJECTIVE: Management of anemia of chronic kidney disease (CKD) often includes subcutaneous or intravenous administration of erythropoietin-stimulating agents (ESAs). Mircera, a pegylated continuous erythropoietin receptor agonist, has a longer duration of action and requires less frequent administration than other ESAs. Pediatric experience with Mircera is limited. We retrospectively reviewed our long-term experience of Mircera in a national pediatric nephrology center. METHODS: Patients were identified via an electronic patient record database...
2023: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38124275/a-population-based-and-clinical-cohort-validation-of-the-novel-consensus-definition-of-metabolic-hyperferritinemia
#36
JOURNAL ARTICLE
Wen-Yue Liu, Li-You Lian, Huai Zhang, Sui-Dan Chen, Xin-Zhe Jin, Ni Zhang, Chen-Hui Ye, Wen-Ying Chen, George Goh Boon Bee, Fu-Di Wang, Luca Miele, Elena Corradini, Luca Valenti, Ming-Hua Zheng
BACKGROUND: There is limited data on the clinical significance of metabolic hyperferritinemia (MHF) based on the most recent consensus. We aimed to validate the clinical outcomes of MHF in general population and biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD) patients. METHODS: NHANES database and PERSONS cohort were included. MHF was defined as elevated serum ferritin with metabolic dysfunction (MD) and stratified into different grades according to ferritin (grade 1: 200 [females]/300 [males] - 550 ng/ml; grade 2: 550 - 1000 ng/ml; grade 3: > 1000 ng/ml)...
December 20, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38115334/atypical-cutaneous-presentation-of-aosd-with-persistent-itchy-urticaria-a-case-report
#37
JOURNAL ARTICLE
Jingfeng Lou, Xingping Zhang
RATIONALE: Adult-onset Still's disease (AOSD) is a rare multisystem disorder considered a complex autoinflammatory syndrome. The clinical and biological features of AOSD typically include a high fever with arthritic symptoms, evanescent skin rash, sore throat, striking neutrophilic leukocytosis, hyperferritinemia, and abnormal liver function. The typical rash and fever are important diagnostic clues for AOSD. Here, we report a case of atypical rash manifesting as persistent itchy urticaria...
December 15, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/38072426/-management-of-iron-overload-during-pregnancy-and-childbirth-in-a-patient-with-ferroportin-disease
#38
JOURNAL ARTICLE
Keito Ohara, Noriko Tsuge, Shinichiro Watanabe, Hitomi Eda, Fumiya Ogasawara, Takumi Kondo, Shohei Yoshida, Kensuke Kojima
An asymptomatic woman in her early 40s with a history of hyperferritinemia (5,412 ng/ml) was referred to our hospital after repeated phlebotomy for hemosiderosis. She had unexplained hyperferritinemia, low-normal transferrin saturation, and high hepcidin levels, in the absence of iron overload-induced organ injury. She was diagnosed with ferroportin disease based on detection of the SLC40A1 variant SLC40A1 c.485_487del (p.Val162del) on genetic analysis. Her ferritin levels remained stable during pregnancy, and postpartum anemia was successfully treated with 2-week oral iron therapy...
2023: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/38062158/hyperferritinemia-among-very-low-birthweight-infants-in-thailand-a-prospective-cohort-study
#39
JOURNAL ARTICLE
Cholticha Laohajeeraphan, Chaicharoen Tantanate, Robert D Christensen, Sopapan Ngerncham
OBJECTIVES: To determine the incidence of hyperferritinemia in VLBW infants, and its association with neonatal morbidity. STUDY DESIGN: Prospective cohort study in a tertiary-level hospital in Bangkok, from March 2022 to January 2023. Serum ferritin (SF) was measured in VLBW infants at one month and repeated monthly for those with hyperferritinemia (SF > 300 ng/mL). RESULTS: Gestational age and birth weight were 29...
December 7, 2023: Journal of Perinatology: Official Journal of the California Perinatal Association
https://read.qxmd.com/read/38053936/lysinuric-protein-intolerance-caused-by-a-homozygous-slc7a7-deletion-and-presented-with-hyperferritinemia-and-osteoporosis-in-two-siblings
#40
Irem Kalay, Hüseyin Aykut, Zuhal Caliskan, Gökhan Yigit, Bernd Wollnik
Lysinuric protein intolerance (LPI) is a rare, inherited aminoaciduria caused by biallelic pathogenic variants in the amino acid transporter gene SLC7A7 (OMIM *603593). Individuals with LPI show extreme variability in their clinical presentation, and LPI is included in the differential diagnosis of several disorders such as urea cycle disorders, lysosomal storage diseases, malabsorption diseases, autoimmune disorders, hemochromatosis, and osteoporosis. The phenotypic variability of LPI and the lack of a specific clinical presentation have caused various misdiagnoses...
December 2023: Molecular Genetics and Metabolism Reports
keyword
keyword
120889
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.